Walleye Capital LLC Increases Stock Holdings in Maximus, Inc. $MMS

Walleye Capital LLC raised its holdings in shares of Maximus, Inc. (NYSE:MMS) by 20.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 162,355 shares of the health services provider’s stock after acquiring an additional 27,612 shares during the quarter. Walleye Capital LLC owned approximately 0.29% of Maximus worth $11,397,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Caitong International Asset Management Co. Ltd increased its stake in shares of Maximus by 17,533.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider’s stock worth $36,000 after purchasing an additional 526 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of Maximus by 37.5% in the second quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock worth $58,000 after acquiring an additional 227 shares during the last quarter. Bayforest Capital Ltd purchased a new stake in shares of Maximus in the second quarter valued at $61,000. Parkside Financial Bank & Trust boosted its stake in shares of Maximus by 21.7% during the second quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock valued at $62,000 after acquiring an additional 157 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in Maximus by 60.4% during the 2nd quarter. GAMMA Investing LLC now owns 1,174 shares of the health services provider’s stock worth $82,000 after purchasing an additional 442 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Insider Activity

In related news, insider Michelle F. Link sold 4,039 shares of the stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the completion of the sale, the insider owned 19,542 shares of the company’s stock, valued at approximately $1,697,027.28. This represents a 17.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

MMS has been the subject of a number of recent research reports. Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, October 27th. Weiss Ratings raised shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $90.00.

Maximus Price Performance

Maximus stock opened at $84.60 on Friday. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $92.50. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.64 and a current ratio of 1.64. The firm has a 50 day moving average price of $85.43 and a 200 day moving average price of $80.33. The company has a market cap of $4.61 billion, a price-to-earnings ratio of 15.22 and a beta of 0.56.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, November 20th. The health services provider reported $1.62 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). Maximus had a return on equity of 25.23% and a net margin of 5.87%.The firm had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.34 billion. During the same quarter in the previous year, the company earned $1.46 earnings per share. The company’s quarterly revenue was up .2% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. Sell-side analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, December 1st. Stockholders of record on Friday, November 14th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, November 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. Maximus’s payout ratio is presently 21.58%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.